Targeting PIM kinase as a therapeutic strategy in human hepatoblastomaLaura L. Stafman, Elizabeth A. Beierle|Oncotarget|2018Cited by 30
Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of NeuroblastomaLauren A. Gillory, Elizabeth A. Beierle|PLoS ONE|2013Cited by 29
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived XenograftsEvan F. Garner, Elizabeth A. Beierle|Scientific Reports|2018Cited by 24
PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cellsLaura L. Stafman, Elizabeth A. Beierle|PLoS ONE|2019Cited by 15
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastomaRaoud Marayati, Elizabeth A. Beierle|Scientific Reports|2021Cited by 12